Search | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Supportive care in severe and very severe aplastic anemia

    ... strategies (immunosuppression or SCT) but also involves supportive treatment as a crucial part of patient care. Patients are threatened by complications of cytopenia . Here, we ...

    Research Article last updated 07/20/2018 - 5:14pm.

  2. Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine*.

    ... subtype of MDS were randomized to azacitidine or best supportive care (BSC). After 56 d, patients randomized to BSC with disease ...

    Research Article last updated 07/20/2018 - 5:14pm.

  3. A Primary Care Approach to Myelodysplastic Syndromes

    ... life expectancy and improve quality of life. Primary care physicians (PCPs) are often involved in the process of diagnosis and ... of life by ensuring early referral and participating in supportive management. There is also a shortage of oncologists which increases ...

    Research Article last updated 07/20/2018 - 5:15pm.

  4. Effects of azacitidine compared with conventional care regimens in elderly (≥ 75 years) patients with higher-risk myelodysplastic syndromes.

    ... analysis compared azacitidine (AZA) to conventional care regimens (CCR) and their associated overall survival (OS) and ... tolerated compared with CCR, which was primarily best supportive care (67%). Grade 3-4 anemia , neutropenia , and ...

    Research Article last updated 07/20/2018 - 5:14pm.

  5. Differences in community and academic practice patterns for newly diagnosed myelodysplastic syndromes (MDS) patients

    ... study year with 1-year follow-up data. Treatment choices (supportive, active, and transplant) were stratified by the international ... (IPSS-R), then separated into groups by location of care and age (<65 or 65+ years). Academic-based care was any contact with the ...

    Research Article last updated 07/20/2018 - 5:15pm.

  6. Current and future management options for myelodysplastic syndromes.

    ... and decitabine . Prior to these developments, supportive care measures consisting of blood and platelet transfusions, ...

    Research Article last updated 07/20/2018 - 5:14pm.

  7. Myelodysplastic syndromes: therapy and outlook

    ... available for those who previously would have received supportive care alone. Each treatment can achieve hematologic improvement and enhance ...

    Research Article last updated 07/20/2018 - 5:14pm.

  8. Management of the refractory aplastic anemia patient: what are the options?

    ... of severe cytopenias at 6 months after IST. Although supportive care is critical for AA patients, it is of paramount importance for ...

    Research Article last updated 07/20/2018 - 5:15pm.

  9. Management of the refractory aplastic anemia patient: what are the options?

    ... of severe cytopenias at 6 months after IST. Although supportive care is critical for AA patients, it is of paramount importance for ...

    Research Article last updated 07/20/2018 - 5:15pm.

  10. Perceptions of Disease State, Treatment Outcomes, and Prognosis Among Patients with Myelodysplastic Syndromes: Results From an Internet-Based Survey.

    ... disease and between those receiving active treatment and supportive care , and assessed patient-reported outcomes. Results. Among 358 patients ...

    Research Article last updated 07/20/2018 - 5:14pm.